Condition
Myxomatous Mitral Valve Degeneration
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown1
Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
NCT07384871Recruiting
AI-Based Shape and Function Analysis of Mitral Valve Prolapse Using 3D Ultrasound
NCT04067635Unknown
Primary Mitral Regurgitation Repair
Showing all 2 trials